← SynDRA
GSK2816126
SynDRA canonical compound SYN0038021 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | EZH2 |
|---|
| Mechanism of action | histone lysine methyltransferase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- EZH2 INHIBITOR
- Histone-lysine N-methyltransferase EZH2 inhibitor
- histone lysine methyltransferase inhibitor
- EZH2 MODULATOR
Cross-references
Synonyms
- GSK-126
- GSK-2816126
- GSK126
- RefChem:1086196
- EZH2 Inhibitor GSK2816126
- Histone-Lysine N-Methyltransferase EZH2 Inhibitor GSK2816126
- GSK 126
- W4OGW9QZ97
- GSK-2816126A
- FKSFKBQGSFSOSM-QFIPXVFZSA-N
- A9G
- MFCD23381067
- GSK126 HCl
- UNII-W4OGW9QZ97
- GSK-126 HCl
- MLS006010251
- GTPL7012
- orb1306533
- SCHEMBL12180401
- SCHEMBL29352969
- EX-A499
- CHEBI:124921
- GSK-126?
- BDBM50017293
- NSC780041
- NSC789702
- AKOS027322309
- CCG-269895
- CS-1401
- FB43076
- GSK 2816126 [WHO-DD]
- NSC-780041
- NSC-789702
- NCGC00347286-01
- NCGC00347286-13
- AS-16379
- HY-13470
- SMR004701327
Look up GSK2816126 in the interactive SynDRA portal →